المساهمون: Faith Dickerson, Principal Investigator, Stanley Research Program

المصدر: A Double-Blind Placebo-Controlled Trial of the Synbiotic Compound Probio-Tec ABCG for Schizophrenia Patients With and Without Elevated Markers of Gastrointestinal Inflammation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04226898Test

المساهمون: Faith Dickerson, Principal Investigator, Stanley Research Program

المصدر: A Double-Blind Placebo-Controlled Trial of a Sulforaphane Nutraceutical to Reduce the Symptoms of Schizophrenia

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02810964Test

المؤلفون: Stanley Medical Research Institute

المساهمون: Faith Dickerson, PhD, MPH, Head, Stanley Research Program

المصدر: Dickerson F, Stallings C, Vaughan C, Origoni A, Goga J, Khushalani S, Yolken R. Artemisinin reduces the level of antibodies to gliadin in schizophrenia. Schizophr Res. 2011 Jul;129(2-3):196-200. doi: 10.1016/j.schres.2011.04.010. Epub 2011 May 5.
Double-Blind Trial of Artemisinin to Reduce The Symptoms of Schizophrenia

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00753506Test

المؤلفون: Stanley Medical Research Institute

المساهمون: Faith Dickerson, Head, Stanley Research Program

المصدر: A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01242371Test